Found: 14
Select item for more details and to access through your institution.
Hematopoiesis under telomere attrition at the single-cell resolution.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27206-7
- By:
- Publication type:
- Article
Hematopoiesis under telomere attrition at the single-cell resolution.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27206-7
- By:
- Publication type:
- Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
- By:
- Publication type:
- Article
Surfactant Protein D Binds to Coxiella burnetii and Results in a Decrease in Interactions with Murine Alveolar Macrophages.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0136699
- By:
- Publication type:
- Article
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. e369, doi. 10.1016/j.clml.2023.08.001
- By:
- Publication type:
- Article
MDS-439: A Simplified Three-Marker Panel for Myelodysplastic Syndrome Prognostic Outperforms the Well-Established Revised International Prognostic Scoring Systems (IPSS-R).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S351, doi. 10.1016/S2152-2650(21)01813-9
- By:
- Publication type:
- Article
Poster: MDS-439: A Simplified Three-Marker Panel for Myelodysplastic Syndrome Prognostic Outperforms the Well-Established Revised International Prognostic Scoring Systems (IPSS-R).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S229, doi. 10.1016/S2152-2650(21)01442-7
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 338, doi. 10.1016/j.clml.2020.12.025
- By:
- Publication type:
- Article
LILRB4 Expression in CMML and MDS Based on Response to Hypomethylating Agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S341, doi. 10.1016/j.clml.2019.07.343
- By:
- Publication type:
- Article
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. E326, doi. 10.1002/ajh.25991
- By:
- Publication type:
- Article
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 19, p. 3552, doi. 10.1002/cncr.33745
- By:
- Publication type:
- Article
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 17, p. 3113, doi. 10.1002/cncr.33622
- By:
- Publication type:
- Article
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article